API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
EU WC
Listed Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.globenewswire.com/news-release/2024/08/09/2927924/0/en/Avenue-Therapeutics-Reports-Second-Quarter-2024-Financial-Results-and-Recent-Corporate-Highlights.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-15-2024-59166.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-5-2023-58407.pdf
https://www.globenewswire.com/news-release/2023/04/17/2648434/0/en/Avenue-Therapeutics-Announces-Regulatory-Update-Based-on-Type-C-Meeting-with-FDA-and-Next-Steps-in-the-Development-of-IV-Tramadol.html
https://www.prnewswire.com/news-releases/tris-pharma-reports-positive-topline-data-from-clinical-study-of-investigational-pain-therapy-cebranopadol-showing-significantly-less-potential-for-abuse-versus-tramadol-and-oxycodone-301701284.html
https://www.prnewswire.com/news-releases/neuraxpharm-to-increase-branded-business-through-upcoming-acquisition-of-established-products-from-sanofi-301584467.html
https://www.globenewswire.com/news-release/2022/02/16/2385819/0/en/Avenue-Therapeutics-Announces-Outcome-of-FDA-Advisory-Committee-Meeting-on-IV-Tramadol.html
https://www.globenewswire.com/news-release/2021/11/29/2342129/0/en/Avenue-Therapeutics-Announces-FDA-Advisory-Committee-Meeting-to-Review-IV-Tramadol-NDA-Tentatively-Scheduled-for-February-15-2022.html
https://www.globenewswire.com/news-release/2021/11/10/2331064/0/en/Avenue-Therapeutics-Prices-2-6-Million-Underwritten-Public-Offering-of-Common-Stock.html
https://www.marketwatch.com/story/avenue-therapeutics-iv-tramadol-gets-negative-fda-response-271623669087
https://www.business-standard.com/article/news-cm/avenue-therapeutics-receives-complete-response-letter-from-usfda-for-iv-tramadol-120101201077_1.html
https://www.americanpharmaceuticalreview.com/1315-News/568055-FDA-Approves-NDA-for-QDOLO-Oral-Solution/?catid=6262
https://www.biospace.com/article/releases/u-s-fda-approves-athena-bioscience-s-new-drug-application-nda-for-qdolo-tramadol-hydrochloride-oral-solution/
https://www.globenewswire.com/news-release/2020/06/05/2044292/0/en/Avenue-Therapeutics-Announces-Publications-in-Peer-Reviewed-Journals.html
https://www.nationalacademies.org/news/2020/05/there-is-a-lack-of-evidence-transparency-about-ingredients-to-support-use-of-compounded-topical-pain-creams-says-new-report
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-4-2020-1583324392.pdf
https://www.globenewswire.com/news-release/2020/02/13/1984507/0/en/Avenue-Therapeutics-Announces-New-Drug-Application-for-IV-Tramadol-Accepted-for-Review-by-FDA.html
https://www.fiercepharma.com/pharma/beset-by-lawsuits-and-criticism-u-s-opioid-makers-eye-new-market-india
https://indianexpress.com/article/india/major-drug-bust-at-faridkot-by-fda-cia-teams/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211825
https://www.pharmacompass.com/pdf/news/asclemed-usa-inc-receives-fda-warning-letter-1562147954.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206706
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208708
https://www.prnewswire.com/news-releases/syntrix-pharmaceuticals-announces-publication-of-positive-double-blind-clinical-trials-showing-desmetramadol-has-the-analgesic-and-side-effect-profile-of-tramadol-without-its-metabolic-liabilities-300861610.html
https://health.economictimes.indiatimes.com/news/pharma/ciplas-subsidiary-to-acquire-us-based-avenue-therapeutics-for-215-million/66607220
https://www.pharmacompass.com/pdf/news/farma-glow-receives-fda-warning-letter-1549432879.pdf
https://www.pharmacompass.com/pdf/news/rxaff-receives-fda-warning-letter-1549433080.pdf
https://seekingalpha.com/article/4207220-osmotica-pharmaceuticals-files-raise-capital-u-s-ipo?source=partner_newsnow
https://health.economictimes.indiatimes.com/news/industry/seized-painkillers-turn-out-to-be-fakes/65657011
https://www.pharmacompass.com/pdf/news/pharmamedics-receives-fda-warning-letter-1549433684.pdf
https://www.pharmacompass.com/pdf/news/pharmacyaffiliatesorg-receives-fda-warning-letter-1549433796.pdf
https://www.pharmacompass.com/pdf/news/medincbiz-receives-fda-warning-letter-1549433870.pdf
https://www.pharmacompass.com/pdf/news/coinrx-receives-fda-warning-letter-1549433729.pdf
https://www.pharmacompass.com/pdf/news/List-of-New-Paragraph-IV-Certifications-as-of-Aug-21-2018-1534919998.pdf
https://health.economictimes.indiatimes.com/news/pharma/ncb-busts-gurgaon-based-online-pharmacy-for-shipping-illegal-drugs/65271399
http://www.pharmexec.com/congress-feds-fda-take-action-combat-opioid-crisis
https://www.raps.org/news-and-articles/news-articles/2018/6/fda-warns-korean-australian-drugmakers-online-op?utm_source=Email&utm_medium=Informz&utm_campaign=Informz-Emails&_zs=VHOsL1&_zl=vjkU4
https://www.reuters.com/article/us-fda-opioid/fda-sends-warning-letters-to-nine-online-marketers-over-opioids-idUSKCN1J12A1
https://endpts.com/another-cheap-old-drug-is-being-freshened-up-for-brand-pricing-in-the-us/
https://health.economictimes.indiatimes.com/news/pharma/govt-brings-isis-drug-tramadol-under-narcotics-law-regulation/63967996
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-18-2018-1524029703.pdf
http://www.theweek.co.uk/92343/nhs-accused-of-creating-drug-addicts-as-opioid-use-soars
http://www.raps.org/Regulatory-Focus/News/2017/09/05/28414/FDA-Warns-Drugmaker-Over-Opioid-Marketing-Materials/?utm_source=Email&utm_medium=Informz&utm_campaign=Informz-Emails
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206885